BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22359649)

  • 1. Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor.
    Chen CR; Salazar LM; McLachlan SM; Rapoport B
    PLoS One; 2012; 7(2):e31973. PubMed ID: 22359649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
    Hamidi S; Chen CR; McLachlan SM; Rapoport B
    Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.
    Chen CR; McLachlan SM; Rapoport B
    Endocrinology; 2009 Jul; 150(7):3401-8. PubMed ID: 19299457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation.
    Chen CR; McLachlan SM; Rapoport B
    Endocrinology; 2010 Apr; 151(4):1940-7. PubMed ID: 20181794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody protection reveals extended epitopes on the human TSH receptor.
    Latif R; Teixeira A; Michalek K; Ali MR; Schlesinger M; Baliram R; Morshed SA; Davies TF
    PLoS One; 2012; 7(9):e44669. PubMed ID: 22957097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.
    Chen CR; McLachlan SM; Rapoport B
    Endocrinology; 2008 Jul; 149(7):3427-34. PubMed ID: 18388191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
    Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
    Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
    Sanders J; Miguel RN; Furmaniak J; Smith BR
    Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.
    Núñez Miguel R; Sanders J; Sanders P; Young S; Clark J; Kabelis K; Wilmot J; Evans M; Roberts E; Hu X; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2012 Oct; 49(2):137-51. PubMed ID: 22829655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.
    Chen CR; Salazar LM; McLachlan SM; Rapoport B
    Endocrinology; 2012 Oct; 153(10):5058-67. PubMed ID: 23002040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
    Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
    Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
    Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.
    Chen CR; McLachlan SM; Hubbard PA; McNally R; Murali R; Rapoport B
    Thyroid; 2018 Jul; 28(7):933-940. PubMed ID: 29845889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hinge region of human thyroid-stimulating hormone (TSH) receptor operates as a tunable switch between hormone binding and receptor activation.
    Majumdar R; Dighe RR
    PLoS One; 2012; 7(7):e40291. PubMed ID: 22792265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.
    Sanders P; Young S; Sanders J; Kabelis K; Baker S; Sullivan A; Evans M; Clark J; Wilmot J; Hu X; Roberts E; Powell M; Núñez Miguel R; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2011 Apr; 46(2):81-99. PubMed ID: 21247981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
    Núñez Miguel R; Sanders J; Chirgadze DY; Blundell TL; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2008 Sep; 41(3):145-64. PubMed ID: 18606720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.
    Mizutori Y; Chen CR; McLachlan SM; Rapoport B
    Mol Endocrinol; 2008 May; 22(5):1171-82. PubMed ID: 18218728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling.
    Núñez Miguel R; Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Blundell TL; Rees Smith B; Furmaniak J
    Thyroid; 2004 Dec; 14(12):991-1011. PubMed ID: 15650352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity.
    Chen CR; McLachlan SM; Rapoport B
    Endocrinology; 2007 May; 148(5):2375-82. PubMed ID: 17272389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain.
    Marcinkowski P; Kreuchwig A; Mendieta S; Hoyer I; Witte F; Furkert J; Rutz C; Lentz D; Krause G; Schülein R
    Mol Pharmacol; 2019 Oct; 96(4):452-462. PubMed ID: 31399504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.